Colleen Druzgal

Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial

Leonardo R. Brandão, Matteo Luciani, Lisa Bomgaars et al. · The Lancet Haematology · 2020 · 149 citations · Full text

Medicine, Pediatrics, Pharmacotherapy +12

Inhibition of nuclear factor-κB and target genes during combined therapy with proteasome inhibitor bortezomib and reirradiation in patients with recurrent head-and-neck squamous cell carcinoma

Carter Van Waes, Angela A. Chang, Peter F. Lebowitz et al. · International Journal of Radiation Oncology*Biology*Physics · 2005 · 117 citations

Medicine, Oncology, Radiation Oncology +16

A pilot study of longitudinal serum cytokine and angiogenesis factor levels as markers of therapeutic response and survival in patients with head and neck squamous cell carcinoma

Colleen Druzgal, Zhong Chen, Ning T. Yeh et al. · Head & Neck · 2005 · 98 citations

Medicine, Cancer Biology, Oncology +14

Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism

Neil A. Goldenberg, John M. Kittelson, Thomas C. Abshire et al. · JAMA · 2022 · 94 citations · Full text

Medicine, Hematology, Internal Medicine +17

Edoxaban for Thromboembolism Prevention in Pediatric Patients With Cardiac Disease

Michael A. Portman, Michael A. Portman, Jeffrey P. Jacobs et al. · Journal of the American College of Cardiology · 2022 · 59 citations

Medicine, Pediatrics, Pharmacotherapy +15